{
    "title": "IMV Inc. Launches Plans to Advance Clinical Development of a Vaccine Candidate Against COVID-19",
    "description": "DARTMOUTH, Nova Scotia--(BUSINESS WIRE)--IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company (the \u201cCompany\u201d or \u201cIMV\u201d), today announced that it is advancing the clinical development of a DPX-based vaccine candidate against COVID-19. Va\u2026",
    "content": "DARTMOUTH Nova Scotia BUSINESS WIRE IMV Inc Nasdaq IMV TSX IMV a clinical stage biopharmaceutical company the Company or IMV today announced that it is advancing the clinical development of a DPX based vaccine candidate against COVID Vaccin chars"
}